Impact BioMedical, Inc. (IBO) — Financial Flexibility Index
Impact BioMedical, Inc. (IBO) has a Financial Flexibility Index of -0.07x as of September 2025. Free cash flow of $-1.99 Million (operating CF $-1.99 Million minus capex $0.00) represents 0% of total liabilities ($27.06 Million). Check IBO strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Impact BioMedical, Inc. Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Impact BioMedical, Inc. across 8 annual periods. See Impact BioMedical, Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Impact BioMedical, Inc. (2017–2024)
Year-by-year free cash flow to debt coverage for Impact BioMedical, Inc.. For the full company profile including market capitalisation, see market cap of Impact BioMedical, Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.43x | $-5.64 Million | $-5.64 Million | $13.05 Million | ▼ -149.5% |
| 2023 | -0.17x | $-2.83 Million | $-2.85 Million | $16.37 Million | ▲ +43.5% |
| 2022 | -0.31x | $-4.24 Million | $-4.33 Million | $13.83 Million | ▲ +89.2% |
| 2021 | -2.84x | $-2.97 Million | $-3.25 Million | $1.05 Million | ▼ -19272.8% |
| 2020 | -0.01x | $-1.14K | $-1.14K | $78.03K | ▲ +99.7% |
| 2019 | -5.54x | $-120.46K | $-121.98K | $21.72K | ▼ -54.7% |
| 2018 | -3.58x | $-71.99K | $-71.99K | $20.09K | ▲ +71.5% |
| 2017 | -12.59x | $-320.34K | $-320.34K | $25.44K | — |